| PACIRA BIOSCIENCES |
| USA |
| Gesundheit |
| US6951271005 / A1H68T |
| 82P (Frankfurt) / PCRX (NASDAQ) |
| FRA:82P, ETR:82P, 82P:GR, NASDAQ:PCRX |
| - |
| https://www.pacira.com/ |
|
Pacira BioSciences, Inc. is a specialty biopharmaceutical company focused on non-opioid pain management and regenerative health solutions. Pacira BioSciences develops, manufactures, markets, distributes, and sells therapies used across postsurgical, ..
>Volltext.. |
| 895.78 Mio. EUR |
| 1036.61 Mio. EUR |
| 665.39 Mio. EUR |
| 100.58 Mio. EUR |
| 13.05 Mio. EUR |
| 0.31 EUR |
| 367.5 Mio. EUR |
| 183.59 Mio. EUR |
| 167.35 Mio. EUR |
| 2.06 |
| 9.04% |
| - |
| - |
| - |
| - |
| - |
| PACIRA |
| 09.10.26 |
|